- Page 1 and 2:
- 1 - Luxembourg, January 25th to 2
- Page 3 and 4:
Table of content PREFACE ..........
- Page 5 and 6:
Preface In 1998, we organized the f
- Page 7 and 8:
Acknowledgments This meeting has be
- Page 9 and 10:
Group B (15h00 - 17h00) Session V.
- Page 11 and 12:
- 11 - Exhibition
- Page 13 and 14:
Visit our Expo (in alphabetical ord
- Page 15 and 16:
Thursday January 26th, 2006 (Early
- Page 17 and 18:
Thursday January 26th, 2006 (Evenin
- Page 19 and 20:
Regulation of inflammation and gluc
- Page 21 and 22:
Saturday January 28th, 2006 (Early
- Page 23 and 24:
Oral presentations (by alphabetical
- Page 25 and 26:
4: : Lottin S, Vercoutter-Edouart A
- Page 27 and 28:
the B-Raf/mitogen-activated/extrace
- Page 29 and 30:
Albertini MC, Accorsi A, Citterio B
- Page 31 and 32:
AP-1-dependent gene expression in s
- Page 33 and 34:
Jaks and cytokine receptors - an in
- Page 35 and 36:
The Role of Met-Gab1 Signalling in
- Page 37 and 38:
The mammalian tumor suppressor Scri
- Page 39 and 40:
SIGNAL TRANSDUCTION BY STRESS-ACTIV
- Page 41 and 42:
Title to be announced Caroline Dive
- Page 43 and 44:
Mechanisms of DNA methylation in ma
- Page 45 and 46:
Blocking the "4 Integrin-Paxillin I
- Page 47 and 48:
Regulation of NF-kB-dependent trans
- Page 49 and 50:
The immunomodulator AS101 induces g
- Page 51 and 52:
Signaling pathways leading to the a
- Page 53 and 54:
Boute, N., Jockers, R. and Issad, T
- Page 55 and 56:
Jespsen JS, Sorensen MD and Wengel
- Page 57 and 58:
8. Nishikawa, H., Kawai, K., Tanaka
- Page 59 and 60:
9) Proteome analysis of rat pancrea
- Page 61 and 62:
MicroRNA is an anti-apoptotic facto
- Page 63 and 64:
Resveratrol inhibits phorbol ester-
- Page 65 and 66:
Cross-talk between angiotensin II a
- Page 67 and 68:
Multiple role of histamine H 1 rece
- Page 69 and 70:
PI3K Targeting by the Beta-GBP Cyto
- Page 71 and 72:
D.P. Chopra, R.E. Menard, J. Janusz
- Page 73 and 74:
[2] Meijer, L., Flajolet, M. and Gr
- Page 75 and 76:
[4] Niemand, C., Nimmesgern, A., Ha
- Page 77 and 78:
Oncogenic signaling by mutant p53 M
- Page 79 and 80:
activity of the Peroxisome Prolifer
- Page 81 and 82:
Restauration of SHIP-1 activity in
- Page 83 and 84:
Hypoxia Signaling. Impact on Tumor
- Page 85 and 86:
5. Sokolov EI, Zykov KA, Pukhalsky
- Page 87 and 88:
HOW ANTITOXIC AND ANTICANCER AGENTS
- Page 89 and 90:
Listeria monocytogenes induced Rac1
- Page 91 and 92:
Epigenetic Regulation of Stem Cell
- Page 93 and 94:
Survey on in vitro cell death induc
- Page 95 and 96:
Distinct roles of IRF-3 and IRF-7 i
- Page 97 and 98:
Redox-Sensitive Transcription Facto
- Page 99 and 100:
Epigenic control of MHC2TA transcri
- Page 101 and 102:
Attenuation of MSK1-driven NF-kB ge
- Page 103 and 104:
Talking to chromatin: Silencers Sil
- Page 105 and 106:
Ubiquitin ligase Smurf1 controls os
- Page 107 and 108:
Workshop presentations (by alphabet
- Page 109 and 110:
Ambion MicroRNAs (miRNAs) are small
- Page 111 and 112:
Organizer: BIOBASE GmbH Date: Janua
- Page 113 and 114:
Reliable and efficient gene Knock-d
- Page 115 and 116:
Exploring ubiquitin signaling with
- Page 117 and 118:
Poster presentations Poster are cla
- Page 119 and 120:
Session I : protein domains Poster
- Page 121 and 122:
Session I : protein domains Poster
- Page 123 and 124:
Session I : protein domains Poster
- Page 125 and 126:
Notes Notes - 125 -
- Page 127 and 128:
Session II. Receptor signaling and
- Page 129 and 130:
Session II : Receptor signaling and
- Page 131 and 132:
Session II : Receptor signaling and
- Page 133 and 134:
Session II : Receptor signaling and
- Page 135 and 136:
Session II : Receptor signaling and
- Page 137 and 138:
Session II : Receptor signaling and
- Page 139 and 140:
Session II : Receptor signaling and
- Page 141 and 142:
Session II : Receptor signaling and
- Page 143 and 144:
Session II : Receptor signaling and
- Page 145 and 146:
Session II : Receptor signaling and
- Page 147 and 148:
Session II : Receptor signaling and
- Page 149 and 150:
Session II : Receptor signaling and
- Page 151 and 152:
Session II : Receptor signaling and
- Page 153 and 154:
Session II : Receptor signaling and
- Page 155 and 156:
Session II : Receptor signaling and
- Page 157 and 158:
Session II : Receptor signaling and
- Page 159 and 160:
Session II : Receptor signaling and
- Page 161 and 162:
Session II : Receptor signaling and
- Page 163 and 164:
Session II : Receptor signaling and
- Page 165 and 166:
Session II : Receptor signaling and
- Page 167 and 168:
Session II : Receptor signaling and
- Page 169 and 170:
Session II : Receptor signaling and
- Page 171 and 172:
Session II : Receptor signaling and
- Page 173 and 174:
Session II : Receptor signaling and
- Page 175 and 176:
Session II : Receptor signaling and
- Page 177 and 178:
Session II : Receptor signaling and
- Page 179 and 180:
Session II : Receptor signaling and
- Page 181 and 182:
Notes Notes - 181 -
- Page 183 and 184:
Session III. Protein kinase cascade
- Page 185 and 186:
Session III : Protein kinase cascad
- Page 187 and 188:
Session III : Protein kinase cascad
- Page 189 and 190:
Session III : Protein kinase cascad
- Page 191 and 192:
Session III : Protein kinase cascad
- Page 193 and 194:
Session III : Protein kinase cascad
- Page 195 and 196:
Session III : Protein kinase cascad
- Page 197 and 198:
Session III : Protein kinase cascad
- Page 199 and 200:
Session III : Protein kinase cascad
- Page 201 and 202:
Session III : Protein kinase cascad
- Page 203 and 204:
Session III : Protein kinase cascad
- Page 205 and 206:
Session III : Protein kinase cascad
- Page 207 and 208:
Session III : Protein kinase cascad
- Page 209 and 210:
Session III : Protein kinase cascad
- Page 211 and 212:
Session III : Protein kinase cascad
- Page 213 and 214:
Session III : Protein kinase cascad
- Page 215 and 216:
Session III : Protein kinase cascad
- Page 217 and 218:
Session III : Protein kinase cascad
- Page 219 and 220:
Session III : Protein kinase cascad
- Page 221 and 222:
Session III : Protein kinase cascad
- Page 223 and 224:
Session III : Protein kinase cascad
- Page 225 and 226:
Session III : Protein kinase cascad
- Page 227 and 228:
Session III : Protein kinase cascad
- Page 229 and 230:
Session III : Protein kinase cascad
- Page 231 and 232:
Session III : Protein kinase cascad
- Page 233 and 234:
Session III : Protein kinase cascad
- Page 235 and 236:
Session III : Protein kinase cascad
- Page 237 and 238:
Session III : Protein kinase cascad
- Page 239 and 240:
Session III : Protein kinase cascad
- Page 241 and 242:
Session III : Protein kinase cascad
- Page 243 and 244:
Session III : Protein kinase cascad
- Page 245 and 246:
Session III : Protein kinase cascad
- Page 247 and 248:
Session III : Protein kinase cascad
- Page 249 and 250:
Session III : Protein kinase cascad
- Page 251 and 252:
Session III : Protein kinase cascad
- Page 253 and 254:
Session III : Protein kinase cascad
- Page 255 and 256:
Notes Notes - 255 -
- Page 257 and 258:
Session IV. Protein kinase inhibito
- Page 259 and 260:
IV. Protein kinase inhibitors: insi
- Page 261 and 262:
IV. Protein kinase inhibitors: insi
- Page 263 and 264:
Notes - 263 -
- Page 265 and 266:
- 265 -
- Page 267 and 268:
V. Phosphatases as key cell signali
- Page 269 and 270:
V. Phosphatases as key cell signali
- Page 271 and 272:
V. Phosphatases as key cell signali
- Page 273 and 274:
Notes - 273 -
- Page 275 and 276:
- 275 -
- Page 277 and 278:
VI. Proteasome degradation pathways
- Page 279 and 280:
VI. Proteasome degradation pathways
- Page 281 and 282:
Session VII. Stem cell specific cel
- Page 283 and 284:
Notes - 283 -
- Page 285 and 286:
VIII. Inflammation specific signali
- Page 287 and 288:
VIII. Inflammation specific signali
- Page 289 and 290:
VIII. Inflammation specific signali
- Page 291 and 292:
VIII. Inflammation specific signali
- Page 293 and 294:
VIII. Inflammation specific signali
- Page 295 and 296:
VIII. Inflammation specific signali
- Page 297 and 298:
VIII. Inflammation specific signali
- Page 299 and 300:
VIII. Inflammation specific signali
- Page 301 and 302:
VIII. Inflammation specific signali
- Page 303 and 304:
VIII. Inflammation specific signali
- Page 305 and 306:
VIII. Inflammation specific signali
- Page 307 and 308:
VIII. Inflammation specific signali
- Page 309 and 310:
VIII. Inflammation specific signali
- Page 311 and 312:
VIII. Inflammation specific signali
- Page 313 and 314:
VIII. Inflammation specific signali
- Page 315 and 316:
VIII. Inflammation specific signali
- Page 317 and 318:
VIII. Inflammation specific signali
- Page 319 and 320:
VIII. Inflammation specific signali
- Page 321 and 322:
Notes - 321 -
- Page 323 and 324:
- 323 -
- Page 325 and 326:
Session IX. Novel compounds targeti
- Page 327 and 328:
Session IX. Novel compounds targeti
- Page 329 and 330:
Session IX. Novel compounds targeti
- Page 331 and 332:
Session IX. Novel compounds targeti
- Page 333 and 334:
Session X : Cell death in cancer -
- Page 335 and 336:
Session X : Cell death in cancer Po
- Page 337 and 338:
Session X : Cell death in cancer Po
- Page 339 and 340:
Session X : Cell death in cancer Po
- Page 341 and 342:
Session X : Cell death in cancer Po
- Page 343 and 344:
Session X : Cell death in cancer Po
- Page 345 and 346:
Session X : Cell death in cancer Po
- Page 347 and 348:
Session X : Cell death in cancer Po
- Page 349 and 350:
Session X : Cell death in cancer Po
- Page 351 and 352:
Session X : Cell death in cancer Po
- Page 353 and 354:
Session X : Cell death in cancer Po
- Page 355 and 356:
Session X : Cell death in cancer Po
- Page 357 and 358:
Session X : Cell death in cancer Po
- Page 359 and 360:
Session X : Cell death in cancer Po
- Page 361 and 362:
Session X : Cell death in cancer Po
- Page 363 and 364:
Session X : Cell death in cancer Po
- Page 365 and 366:
Session X : Cell death in cancer Po
- Page 367 and 368:
Session X : Cell death in cancer Po
- Page 369 and 370:
Session X : Cell death in cancer Po
- Page 371 and 372:
Session X : Cell death in cancer Po
- Page 373 and 374:
Session X : Cell death in cancer Po
- Page 375 and 376:
Session X : Cell death in cancer Po
- Page 377 and 378:
Session X : Cell death in cancer Po
- Page 379 and 380:
Session X : Cell death in cancer Po
- Page 381 and 382:
Session X : Cell death in cancer Po
- Page 383 and 384:
Session X : Cell death in cancer Po
- Page 385 and 386:
Session X : Cell death in cancer Po
- Page 387 and 388:
Session X : Cell death in cancer Po
- Page 389 and 390:
Session X : Cell death in cancer Po
- Page 391 and 392:
Session X : Cell death in cancer Po
- Page 393 and 394:
Session X : Cell death in cancer Po
- Page 395 and 396:
Session X : Cell death in cancer Po
- Page 397 and 398:
Session X : Cell death in cancer Po
- Page 399 and 400:
Session X : Cell death in cancer Po
- Page 401 and 402:
Session X : Cell death in cancer Po
- Page 403 and 404:
Session X : Cell death in cancer Po
- Page 405 and 406:
Session X : Cell death in cancer Po
- Page 407 and 408:
Session X : Cell death in cancer Po
- Page 409 and 410:
Session X : Cell death in cancer Po
- Page 411 and 412:
Session X : Cell death in cancer Po
- Page 413 and 414:
Session X : Cell death in cancer Po
- Page 415 and 416:
Session X : Cell death in cancer Po
- Page 417 and 418:
Session X : Cell death in cancer Po
- Page 419 and 420:
Session X : Cell death in cancer Po
- Page 421 and 422:
Session X : Cell death in cancer Po
- Page 423 and 424:
Session X : Cell death in cancer Po
- Page 425 and 426:
Session X : Cell death in cancer Po
- Page 427 and 428:
Session X : Cell death in cancer Po
- Page 429 and 430:
Session X : Cell death in cancer Po
- Page 431 and 432:
Session X : Cell death in cancer Po
- Page 433 and 434:
Session X : Cell death in cancer Po
- Page 435 and 436:
Session X : Cell death in cancer Po
- Page 437 and 438:
Session X : Cell death in cancer Po
- Page 439 and 440:
Session X : Cell death in cancer Po
- Page 441 and 442:
Session X : Cell death in cancer Po
- Page 443 and 444:
Notes Notes - 443 -
- Page 445 and 446:
Session XI : Cell death and cardiov
- Page 447 and 448:
Session XI: Cell death and cardiova
- Page 449 and 450:
Session XI: Cell death and cardiova
- Page 451 and 452:
Session XI: Cell death and cardiova
- Page 453 and 454:
Session XI: Cell death and cardiova
- Page 455 and 456:
Session XI: Cell death and cardiova
- Page 457 and 458:
Notes - 457 -
- Page 459 and 460:
Session XII : Cell death and neurod
- Page 461 and 462:
Session XII : Cell death and neurod
- Page 463 and 464:
Session XII : Cell death and neurod
- Page 465 and 466:
Session XII : Cell death and neurod
- Page 467 and 468:
Session XII : Cell death and neurod
- Page 469 and 470:
Session XII : Cell death and neurod
- Page 471 and 472:
Session XII : Cell death and neurod
- Page 473 and 474:
Session XII : Cell death and neurod
- Page 475 and 476:
Session XII : Cell death and neurod
- Page 477 and 478:
Session XII : Cell death and neurod
- Page 479 and 480:
Session XII : Cell death and neurod
- Page 481 and 482:
Session XII : Cell death and neurod
- Page 483 and 484:
Session XII : Cell death and neurod
- Page 485 and 486:
Notes - 485 -
- Page 487 and 488:
- 487 -
- Page 489 and 490:
Session XIII : Cell signaling pathw
- Page 491 and 492:
Session XIII : Cell signaling pathw
- Page 493 and 494:
Session XIII : Cell signaling pathw
- Page 495 and 496:
Session XIII : Cell signaling pathw
- Page 497 and 498:
Session XIII : Cell signaling pathw
- Page 499 and 500:
Session XIII : Cell signaling pathw
- Page 501 and 502:
Notes Notes - 501 -
- Page 503 and 504:
Session XIV : Transcriptional and t
- Page 505 and 506:
Session XIV : Transcriptional and t
- Page 507 and 508:
Session XIV : Transcriptional and t
- Page 509 and 510:
Session XIV : Transcriptional and t
- Page 511 and 512:
Session XIV : Transcriptional and t
- Page 513 and 514:
Session XIV : Transcriptional and t
- Page 515 and 516:
Session XIV : Transcriptional and t
- Page 517 and 518:
Session XIV : Transcriptional and t
- Page 519 and 520:
Session XIV : Transcriptional and t
- Page 521 and 522:
Session XIV : Transcriptional and t
- Page 523 and 524:
Session XIV : Transcriptional and t
- Page 525 and 526:
Session XIV : Transcriptional and t
- Page 527 and 528:
Session XIV : Transcriptional and t
- Page 529 and 530:
Session XIV : Transcriptional and t
- Page 531 and 532:
Session XIV : Transcriptional and t
- Page 533 and 534:
Session XIV : Transcriptional and t
- Page 535 and 536:
Session XIV : Transcriptional and t
- Page 537 and 538:
Session XIV : Transcriptional and t
- Page 539 and 540:
Session XIV : Transcriptional and t
- Page 541 and 542:
Session XIV : Transcriptional and t
- Page 543 and 544:
Session XIV : Transcriptional and t
- Page 545 and 546:
Session XIV : Transcriptional and t
- Page 547 and 548:
Session XIV : Transcriptional and t
- Page 549 and 550:
Session XIV : Transcriptional and t
- Page 551 and 552:
Session XIV : Transcriptional and t
- Page 553 and 554:
Session XIV : Transcriptional and t
- Page 555 and 556:
Session XIV : Transcriptional and t
- Page 557 and 558:
Session XIV : Transcriptional and t
- Page 559 and 560:
Session XIV : Transcriptional and t
- Page 561 and 562:
Session XIV : Transcriptional and t
- Page 563 and 564:
Session XIV : Transcriptional and t
- Page 565 and 566:
Session XIV : Transcriptional and t
- Page 567 and 568:
Session XIV : Transcriptional and t
- Page 569 and 570:
Session XIV : Transcriptional and t
- Page 571 and 572:
Session XIV : Transcriptional and t
- Page 573 and 574:
Session XIV : Transcriptional and t
- Page 575 and 576:
Session XIV : Transcriptional and t
- Page 577 and 578:
Session XIV : Transcriptional and t
- Page 579 and 580:
Session XIV : Transcriptional and t
- Page 581 and 582:
Session XIV : Transcriptional and t
- Page 583 and 584:
Notes Notes - 583 -
- Page 585 and 586:
Session XV : Reactive oxygen specie
- Page 587 and 588:
Session XV : Reactive oxygen specie
- Page 589 and 590:
Session XV : Reactive oxygen specie
- Page 591 and 592:
Notes - 591 -
- Page 593 and 594:
Session XVI : Chemopreventive agent
- Page 595 and 596:
Session XVI : Chemopreventive agent
- Page 597 and 598:
Session XVI : Chemopreventive agent
- Page 599 and 600:
Session XVI : Chemopreventive agent
- Page 601 and 602:
Session XVI : Chemopreventive agent
- Page 603 and 604:
Session XVI : Chemopreventive agent
- Page 605 and 606:
Session XVI : Chemopreventive agent
- Page 607 and 608:
Session XVII : Cell signaling in he
- Page 609 and 610:
Session XVII : Cell signaling in he
- Page 611 and 612:
Session XVII : Cell signaling in he
- Page 613 and 614:
Session XVII : Cell signaling in he
- Page 615 and 616:
Session XVII : Cell signaling in he
- Page 617 and 618:
Session XVII : Cell signaling in he
- Page 619 and 620:
Session XVII : Cell signaling in he
- Page 621 and 622:
Session XVII : Cell signaling in he
- Page 623 and 624:
Session XVII : Cell signaling in he
- Page 625 and 626:
Session XVII : Cell signaling in he
- Page 627 and 628:
Session XVII : Cell signaling in he
- Page 629 and 630:
Session XVII : Cell signaling in he
- Page 631 and 632: Session XVII : Cell signaling in he
- Page 633 and 634: Session XVII : Cell signaling in he
- Page 635 and 636: Session XVII : Cell signaling in he
- Page 637 and 638: Session XVII : Cell signaling in he
- Page 639 and 640: Session XVII : Cell signaling in he
- Page 641 and 642: Session XVII : Cell signaling in he
- Page 643 and 644: Session XVII : Cell signaling in he
- Page 645 and 646: Session XVII : Cell signaling in he
- Page 647 and 648: Session XVII : Cell signaling in he
- Page 649 and 650: Session XVII : Cell signaling in he
- Page 651 and 652: Session XVII : Cell signaling in he
- Page 653 and 654: Session XVII : Cell signaling in he
- Page 655 and 656: Session XVII : Cell signaling in he
- Page 657 and 658: Session XVII : Cell signaling in he
- Page 659 and 660: Session XVII : Cell signaling in he
- Page 661 and 662: Session XVII : Cell signaling in he
- Page 663 and 664: Session XVII : Cell signaling in he
- Page 665 and 666: Session XVII : Cell signaling in he
- Page 667 and 668: Session XVII : Cell signaling in he
- Page 669 and 670: Notes - 669 -
- Page 671 and 672: - 671 -
- Page 673 and 674: - 673 -
- Page 675 and 676: Dr. Nassera Aouali L-1526 Luxembour
- Page 677 and 678: Dr. Giordano Bianchi Clinic of inte
- Page 679 and 680: Mrs. Isabel Burghardt Laboratory of
- Page 681: Pr. Czeslaw Cierniewski 92-215 Lodz
- Page 685 and 686: Mrs. Anissa Fergani INSERM U-692 67
- Page 687 and 688: Dr. Mark Ginsberg Mail code 0726 92
- Page 689 and 690: Dr. Jochen Hefl Division of Signal
- Page 691 and 692: Mr. Jan Jepsen 2100 Copenhagen DNK
- Page 693 and 694: Pr. Young Min Kim Division of Biolo
- Page 695 and 696: Mr. Christoph Lahtz AG Tumorgenetik
- Page 697 and 698: Pr. Etta Livneh 84105 Beer Sheva IS
- Page 699 and 700: Mrs. Rasa Merzvinskyte Department o
- Page 701 and 702: Mr. Gustav Nilsonne Department of L
- Page 703 and 704: Mrs. Christel Péqueux Tumour and D
- Page 705 and 706: Dr. Gabriella Regis Tumor Immunolog
- Page 707 and 708: Dr. Carsten Scheller 97078 Wuerzbur
- Page 709 and 710: Mr. Yoo-Cheol Song Laboratory of Gy
- Page 711 and 712: Dr. Lucia Maria Valatro Laboratori
- Page 713 and 714: Mrs. Jessica Wagener 40225 Duesseld
- Page 715: Pr. Moncef ZOUALI Centre Viggo Pete
Change language